Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors

Clinical trial NCT05388487 · UNKNOWN

Trial details

NCT number: NCT05388487
Sponsor: HighField Biopharmaceuticals Corporation
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2022-02-16
Primary completion: 2025-04-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.